Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. [electronic resource]
- Lancet (London, England) Feb 2008
- 660-667 p. digital
Adrenal Cortex Hormones--therapeutic use Antibodies, Monoclonal--therapeutic use Azathioprine--therapeutic use Belgium Chi-Square Distribution Crohn Disease--drug therapy Female Germany Humans Immunosuppressive Agents--therapeutic use Infliximab Male Methotrexate--therapeutic use Netherlands Statistics, Nonparametric Treatment Outcome